FDA Public Meeting on Chagas Disease Patient-Focused Drug Development
Written by Jennifer Huron on April 28, 2015
Paul Melmeyer, NORD’s Assistant Director of Public Policy, attended the FDA’s public meeting on Chagas Disease Patient-Focused Drug Development on April 28. Chagas is a rare parasitic disease (read NORD’s Rare Disease Report here) that is spread by insects. While it… Read More
